Rxs, OTCs, and others
FDA Roundup: Agency Highlights from July 2024
Check out these important FDA updates from the month of July 2024.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Approval Marks Epysqli as Second Soliris Biosimilar
The approval of eculizumab-aagh offers more treatment options for patients with rare diseases PNH and aHUS.
With FDA Approval, Vonoprozan Offers Options for Nonerosive GERD
The approval offers a first of its kind treatment option for patients living with nonerosive GERD.
FDA, FTC Issue Warnings to Companies Selling Copycat Food Products Containing Delta-8 THC
The companies are marketing products that may violate Federal Trade Commission prohibition of “unfair and deceptive acts in the marketplace.”
Novo Nordisk Once-Weekly Insulin Faces Approval Setback With CRL
Had Novo Nordisk’s insulin icodec secured FDA approval, it would have been the first and only once-weekly basal insulin option for adults with diabetes.
